eOPRA Implant + Magnetic Bead Tracking for Amputation
(TTeOPRA+MB Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new implant system designed to improve prosthetic limb control for individuals with a lower leg amputation. The eOPRA Implant System uses implanted electrodes to enhance communication between the body and prosthetic, while the Magnetic Bead Tracking System tracks muscle movements in real-time. It is best suited for those with a transtibial amputation (below the knee) who can walk at different speeds. Participants should not have severe health conditions or active skin diseases that could interfere with the treatment. As an unphased trial, this study offers a unique opportunity to contribute to groundbreaking research and potentially benefit from innovative technology.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, if you have been on corticosteroids, immune-suppressive therapy, or chemotherapy drugs in the last six months, you may not be eligible to participate.
What prior data suggests that the eOPRA Implant System and Magnetic Bead Tracking System are safe for transtibial amputees?
Research has shown that the eOPRA Implant System, used for higher leg amputations, has raised some safety concerns over time. One study found that although patients experienced better function, there were instances of deep infections and mechanical problems, particularly with longer use.
The Magnetic Bead Tracking System is newer, so less information is available. Early studies are investigating its safety. This system uses small magnets to track muscle movement, aiding in the control of a prosthetic limb. So far, this method appears safe, but more research is needed to fully understand any risks.
In summary, while the eOPRA Implant has some known risks, the Magnetic Bead Tracking System is still under study. Both are promising, but participants should be aware of possible complications.12345Why are researchers excited about this trial?
Researchers are excited about the eOPRA Implant System and Magnetic Bead Tracking System because they offer a novel approach for transtibial amputees. Unlike traditional prosthetics, which rely on sockets, the eOPRA Implant System directly connects to the bone, potentially improving comfort and mobility. Additionally, the Magnetic Bead Tracking System provides advanced tracking of limb movement, which could enhance the precision and function of the prosthetic. Together, these innovations aim to provide a more natural and intuitive experience for amputees, setting them apart from current options.
What evidence suggests that the eOPRA Implant System and Magnetic Bead Tracking System could be effective for amputation?
A previous study demonstrated reliable results with the e-OPRA Implant System in over 100 patients with limb amputations, significantly improving their quality of life. Research indicates that this system connects directly to the bone, making prosthetic limbs feel more natural and comfortable. Studies have shown that patients using these implants reported better movement and satisfaction compared to traditional prosthetics.
The Magnetic Bead Tracking System is still new, but early findings suggest it can help control prosthetic limbs more effectively. This system uses small magnets to track muscle movements and send signals to a robotic prosthesis, potentially allowing for more precise and natural control over the limb. In this trial, both the e-OPRA Implant System and the Magnetic Bead Tracking System will be used together, promising better control and comfort for amputees with their prosthetic limbs.12346Who Is on the Research Team?
Hugh M Herr, PhD
Principal Investigator
Massachusetts Institute of Technology
Matthew J Carty, MD
Principal Investigator
Brigham and Women's Hospital
Are You a Good Fit for This Trial?
This trial is for transtibial amputees, meaning individuals who have had a leg amputation below the knee. Participants should be willing to undergo surgery to implant the e-OPRA and Magnetic Bead Tracking systems and commit to follow-up sessions over approximately 24 months.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Surgery and Implantation
Participants undergo one or more surgeries for the implantation of the e-OPRA Implant System and Magnetic Bead Tracking System
Rehabilitation and Initial Testing
Participants begin rehabilitation and initial testing of the prosthetic system, including stability assessments and EMG control activities
Long-term Follow-up
Participants are monitored for device stability and effectiveness, including walking gait and balance assessments
What Are the Treatments Tested in This Trial?
Interventions
- eOPRA Implant System
- Magnetic Bead Tracking System
Find a Clinic Near You
Who Is Running the Clinical Trial?
Brigham and Women's Hospital
Lead Sponsor
Massachusetts Institute of Technology (MIT)
Collaborator
Integrum
Industry Sponsor